CXC chemokines located in the 4q21 region are up-regulated in breast cancer.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Endocrine-Related Cancer

• Publication date

  2007-12-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1677/ERC.1.01301PMID 18045955
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Constitutive expression of growth regulated oncogene (gro) in human colon carcinoma cells with different metastatic potential and its role in regulating their metastatic phenotype

  2005cited by this paper
• CXC chemokines in angiogenesis.

  2005cited by this paper
• Mitogenic effects of interleukin-8/CXCL8 on cancer cells.

  2005cited by this paper
• PAR-1 Activation on Human Late Endothelial Progenitor Cells Enhances Angiogenesis In Vitro With Upregulation of the SDF-1/CXCR4 System

  2005cited by this paper
• Increased Serum Interleukin-8 in Patients with Early and Metastatic Breast Cancer Correlates with Early Dissemination and Survival

  2004cited by this paper
• Chemokines: multiple levels of leukocyte migration control.

  2004cited by this paper
• Steroid hormone receptors in breast cancer management

  2004cited by this paper
• Cancer and the chemokine network

  2004cited by this paper
• Mechanisms underlying differential expression of interleukin-8 in breast cancer cells

  2004influential reference
• Identification of interleukin‐8 as estrogen receptor‐regulated factor involved in breast cancer invasion and angiogenesis by protein arrays

  2004cited by this paper
• The Role of Chemokines in the Biology and Therapy of Breast Cancer

  2004cited by this paper
• Concentration of interleukin-6 (IL-6), interleukin-8 (IL-8) and interleukin-10 (IL-10) in blood serum of breast cancer patients.

  2003cited by this paper
• IL-8 expression and its possible relationship with estrogen-receptor-negative status of breast cancer cells

  2003influential reference
• Expression of interleukin 8 and not parathyroid hormone-related protein by human breast cancer cells correlates with bone metastasis in vivo.

  2002cited by this paper
• GeneANOVA-gene expression analysis of variance

  2002cited by this paper
• Chemokine receptors: multifaceted therapeutic targets

  2002cited by this paper
• Serum interleukin 6, plasma VEGF, serum VEGF, and VEGF platelet load in breast cancer patients.

  2002cited by this paper
• Involvement of chemokine receptors in breast cancer metastasis

  2001cited by this paper
• Progression and enhancement of metastatic potential after exposure of tumor cells to chemotherapeutic agents.

  2001cited by this paper
• ER beta inhibits proliferation and invasion of breast cancer cells.

  2001cited by this paper
• Identification of CGA as a novel estrogen receptor-responsive gene in breast cancer: an outstanding candidate marker to predict the response to endocrine therapy.

  2001cited by this paper
• Constitutive IkappaB kinase activity correlates with nuclear factor-kappaB activation in human melanoma cells.

  2001cited by this paper
• ERβ Inhibits Proliferation and Invasion of Breast Cancer Cells.

  2001cited by this paper
• Constitutive IκB Kinase Activity Correlates with Nuclear Factor-κB Activation in Human Melanoma Cells

  2001cited by this paper
• CXC chemokines in angiogenesis

  2000influential reference
• Differential expression and responsiveness of chemokine receptors (CXCR1–3) by human microvascular endothelial cells and umbilical vein endothelial cells

  2000cited by this paper
• Reduction in serum IL-6 after vacination of breast cancer patients with tumour-associated antigens is related to estrogen receptor status.

  2000cited by this paper
• The biology of chemokines and their receptors.

  2000cited by this paper
• The CXC Chemokine Receptor 2, CXCR2, Is the Putative Receptor for ELR+ CXC Chemokine-Induced Angiogenic Activity1

  2000cited by this paper
• Cytokines IL-1beta, IL-2, IL-6, IL-8, MCP-1, GM-CSF and TNFalpha in patients with epithelial ovarian cancer and their relationship to treatment with paclitaxel.

  2000cited by this paper
• Growth Regulated Oncogene-α expression by murine squamous cell carcinoma promotes tumor growth, metastasis, leukocyte infiltration and angiogenesis by a host CXC Receptor-2 dependent mechanism

  2000cited by this paper
• Real-time reverse transcription-PCR assay for future management of ERBB2-based clinical applications.

  1999cited by this paper
• The chemokine system: redundancy for robust outputs.

  1999cited by this paper
• Short-term primary culture of epithelial cells derived from human breast tumours.

  1998cited by this paper
• Chemokines--chemotactic cytokines that mediate inflammation.

  1998cited by this paper
• Expression of cytokine messenger RNA in normal and neoplastic human breast tissue: Identification of interleukin‐8 as a potential regulatory factor in breast tumours

  1997cited by this paper
• Chemokines induce migrational responses in human breast carcinoma cell lines

  1997cited by this paper
• THE ROLE OF CXC CHEMOKINES AS REGULATORS OF ANGIOGENESIS

  1995cited by this paper
• Constitutive and Cytokine-induced Expression of the Melanoma Growth Stimulatory Activity/GROα Gene Requires Both NF-κB and Novel Constitutive Factors (*)

  1995cited by this paper
• Constitutive and cytokine-induced expression of the melanoma growth stimulatory activity/GRO alpha gene requires both NF-kappa B and novel constitutive factors.

  1995cited by this paper
• Why are estrogen-receptor-negative breast cancers more aggressive than the estrogen-receptor-positive breast cancers?

  1994cited by this paper
• Platelet factor 4 binds to interleukin 8 receptors and activates neutrophils when its N terminus is modified with Glu-Leu-Arg.

  1993cited by this paper
• Scanning mutagenesis of interleukin-8 identifies a cluster of residues required for receptor binding.

  1991cited by this paper
• Estrogen receptor levels and survival of breast cancer patients. A study on patients participating in randomized trials of adjuvant therapy.

  1987cited by this paper
• The meaning and use of the area under a receiver operating characteristic (ROC) curve.

  1982cited by this paper
• Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples.

  1977cited by this paper
• Nonparametric Estimation from Incomplete Observations

  1958cited by this paper
• Histological Grading and Prognosis in Breast Cancer

  1957cited by this paper
• On a Test of Whether one of Two Random Variables is Stochastically Larger than the Other

  1947cited by this paper

• Analysis of the role of cellular autosomal genetic banding position subtyping on clinical prognosis and immune infiltration in colorectal cancer

  2025cites this paper
• Tumor-derived CXCL5 promotes 5-fluorouracil resistance in colorectal cancer cells via p21 downregulation

  2025cites this paper
• Age-related and postmenopausal breast cancer progression and treatment management: The significance of pro-inflammatory cytokines and CXC chemokines

  2025cites this paper
• Molecular Regulation of SASP in Cellular Senescence: Therapeutic Implications and Translational Challenges

  2025cites this paper
• Revisiting the CXCL13/CXCR5 Axis in the Tumor Microenvironment in the Era of Single-cell Omics: Implications for Immunotherapy.

  2024cites this paper
• The adhesion-GPCR ADGRF5 fuels breast cancer progression by suppressing the MMP8-mediated antitumorigenic effects

  2024cites this paper
• CXCL3: A key player in tumor microenvironment and inflammatory diseases.

  2024cites this paper
• Magnetic Particle Imaging Reveals that Iron-Labeled Extracellular Vesicles Accumulate in Brains of Mice with Metastases

  2024cites this paper
• Spatial analyses revealed CXCL5 and SLC6A14 as the markers of microvascular invasion in intrahepatic cholangiocarcinoma

  2024cites this paper
• Roles of Chemokine Axes in Breast Cancer.

  2024cites this paper
• Global transcriptomic analysis of breast cancer and normal mammary epithelial cells infected with Borrelia burgdorferi

  2023cites this paper
• Neonatal administration of synthetic estrogen, diethylstilbestrol to mice up-regulates inflammatory Cxclchemokines located in the 5qE1 region in the vaginal epithelium

  2023influential citation
• Involvement in Tumorigenesis and Clinical Significance of CXCL1 in Reproductive Cancers: Breast Cancer, Cervical Cancer, Endometrial Cancer, Ovarian Cancer and Prostate Cancer

  2023influential citation
• Liver resection modulates hepatic chemokine levels in breast cancer.

  2023cites this paper
• Identification and validation of a T cell marker gene-based signature to predict prognosis and immunotherapy response in gastric cancer

  2023cites this paper
• CXCR2 chemokine receptor - a master regulator in cancer and physiology.

  2023cites this paper
• Unveiling the mechanistic role of the Aryl hydrocarbon receptor in environmentally induced Breast cancer.

  2023cites this paper
• CXC ELR-Positive Chemokines as Diagnostic and Prognostic Markers for Breast Cancer Patients

  2023cites this paper
• The AGEs/RAGE Transduction Signaling Prompts IL-8/CXCR1/2-Mediated Interaction between Cancer-Associated Fibroblasts (CAFs) and Breast Cancer Cells

  2022cites this paper
• Environmental exposure and the role of AhR in the tumor microenvironment of breast cancer

  2022influential citation
• CXCR2 intrinsically drives the maturation and function of neutrophils in mice

  2022cites this paper
• ADSCs stimulated by resistin promote breast cancer cell malignancy via CXCL5 in a breast cancer coculture model

  2022cites this paper
• CXCL13-CXCR5 axis: Regulation in inflammatory diseases and cancer.

  2022cites this paper
• Tumor-associated neutrophils and neutrophil-targeted cancer therapies.

  2022cites this paper
• RCAN1-mediated calcineurin inhibition as a target for cancer therapy

  2022cites this paper
• Plasma CXCL3 Levels Are Associated with Tumor Progression and an Unfavorable Colorectal Cancer Prognosis

  2022cites this paper
• Harnessing the chemokine system to home CAR-T cells into solid tumors

  2022cites this paper
• Chemokines and their receptors: new insights in cancer inflammation

  2022cites this paper
• CXCR2 Mediates Distinct Neutrophil Behavior in Brain Metastatic Breast Tumor

  2022cites this paper
• Comprehensive Analysis of Prognostic Microenvironment-Related Genes in Invasive Breast Cancer

  2022cites this paper
• CXCL3 Signaling in the Tumor Microenvironment.

  2021cites this paper
• A chemokine regulatory loop induces cholesterol synthesis in lung-colonizing triple-negative breast cancer cells to fuel metastatic growth

  2021cites this paper
• Pivotal Role for Cxcr2 in Regulating Tumor-Associated Neutrophil in Breast Cancer

  2021cites this paper
• CXCR2 Levels Correlate with Immune Infiltration and a Better Prognosis of Triple-Negative Breast Cancers

  2021influential citation
• Intervention of IL-8-CXCR2 axis to reverse the resistance to GBM therapies

  2021cites this paper
• Exploration of prognostic biomarkers and therapeutic targets in the microenvironment of bladder cancer based on CXC chemokines.

  2021cites this paper
• Triple-Negative Breast Cancer Cells Recruit Neutrophils by Secreting TGF-β and CXCR2 Ligands

  2021cites this paper
• Mechanisms of glioblastoma resistance to antiangiogenic agents and reversal approaches

  2021cites this paper
• Modulating Properties of Piroxicam, Meloxicam and Oxicam Analogues against Macrophage-Associated Chemokines in Colorectal Cancer

  2021cites this paper
• Clinical significance and biological functions of chemokine CXCL3 in head and neck squamous cell carcinoma

  2021influential citation
• Prognostic and tumor-immune infiltration cell signatures in tamoxifen-resistant breast cancers.

  2021cites this paper
• CXCL3 overexpression affects the malignant behavior of oral squamous cell carcinoma cells via the MAPK signaling pathway.

  2021cites this paper
• The Age-Dependent Characterization of the ER-Alpha Positive Breast Cancer Tumor Microenvironment

  2021cites this paper
• CXCL13 Signaling in the Tumor Microenvironment.

  2021cites this paper
• Molecular mechanism of gossypol mediating CCL2 and IL-8 attenuation in triple-negative breast cancer cells

  2020cites this paper
• Molecular profiling of stroma highlights stratifin as a novel biomarker of poor prognosis in pancreatic ductal adenocarcinoma

  2020cites this paper
• CXCL5/CXCR2 axis in tumor microenvironment as potential diagnostic biomarker and therapeutic target

  2020cites this paper
• The health status alters the pituitary function and reproduction of mice in a Cxcr2-dependent manner

  2020cites this paper
• Using evasins to target the chemokine network in inflammation.

  2020cites this paper
• Detection of Epigenetic Field Defects Using a Weighted Epigenetic Distance-Based Method.

  2020cites this paper
• Stem Cell Transcriptional Networks: Methods and Protocols

  2020cites this paper
• Breast Cancer During Pregnancy: A Marked Propensity to Triple-Negative Phenotype

  2020cites this paper
• Breast Cancer Cells Induce a Pro-inflammatory Response to Mitigate Immune Mediation in a 3D Culture Model

  2020cites this paper
• Cancer-Associated Stemness and Epithelial-to-Mesenchymal Transition Signatures Related to Breast Invasive Carcinoma Prognostic

  2020cites this paper
• Prognostic Value of CXCR2 in Breast Cancer

  2020cites this paper
• Cancer-associated hypersialylated MUC1 drives the differentiation of human monocytes into macrophages with a pathogenic phenotype

  2020cites this paper
• Identification of differentially expressed genes and biological characteristics of colorectal cancer by integrated bioinformatics analysis

  2019cites this paper
• Prognostic and clinicopathological significance of CXCL1 in cancers: a systematic review and meta-analysis

  2019influential citation
• CXCL13 and Its Receptor CXCR5 in Cancer: Inflammation, Immune Response, and Beyond

  2019cites this paper
• Digital WPI Major Qualifying Projects ( All Years ) Major Qualifying Projects January 2008 ACTIVATION OF MACROPHAGES IN VIVO BY GLYCAN LNFPIII

  2019cites this paper
• Low Plasma IL-8 Levels During Chemotherapy Are Predictive of Excellent Long-Term Survival in Metastatic Breast Cancer.

  2019cites this paper
• Bioinformatics-based analysis of TCGA to identify the prognostic biomarkers in HR-positive/HER2-negative tamoxifen-treated breast cancer

  2019cites this paper
• Monoclonal Antibody against CXCL1 (HL2401) as a Novel Agent in Suppressing IL6 Expression and Tumoral Growth

  2019cites this paper
• Interleukin-6 and interleukin-8 serum levels in prognosis of hormone-dependent breast cancer.

  2019cites this paper
• Metastatic Breast Cancer

  2019cites this paper
• The CXC chemokines and CXC chemokine receptors in orange‐spotted grouper (Epinephelus coioides) and their expression after Singapore grouper iridovirus infection

  2019cites this paper
• Resistance to lysosomotropic drugs used to treat kidney and breast cancers involves autophagy and inflammation and converges in inducing CXCL5

  2019cites this paper
• Insights on CXC chemokine receptor 2 in breast cancer: An emerging target for oncotherapy

  2019cites this paper
• CXCL2, a new critical factor and therapeutic target for cardiovascular diseases

  2019cites this paper
• Immunostimulatory and Anti-inflammatory Effect of Ganoderma Lucidum on Breast Cancer Patients

  2018cites this paper
• Transcription factor c-Myb inhibits breast cancer lung metastasis by suppression of tumor cell seeding

  2018cites this paper
• Plac1 Is a Key Regulator of the Inflammatory Response and Immune Tolerance In Mammary Tumorigenesis

  2018cites this paper
• Molecular cloning and biophysical characterization of CXCL3 chemokine.

  2018cites this paper
• Prognostic significance of CXCL5 expression in cancer patients: a meta-analysis

  2018cites this paper
• Molecular and functional characterization of tumor‐induced factor (TIF): Hamster homolog of CXCL3 (GRO&ggr;) displays tumor suppressive activity

  2018cites this paper
• XCL1‐XCR1 pathway promotes trophoblast invasion at maternal‐fetal interface by inducing MMP‐2/MMP‐9 activity

  2018cites this paper
• Functions of the CXC ligand family in the pancreatic tumor microenvironment.

  2018cites this paper
• Forkhead box C1 boosts triple‐negative breast cancer metastasis through activating the transcription of chemokine receptor‐4

  2018cites this paper
• Detection of epigenetic field defects using a weighted epigenetic distance-based method

  2018cites this paper
• XCL 1-XCR 1 pathway

  2018cites this paper
• Human Adipose‐Derived Mesenchymal Stem Cell‐Secreted CXCL1 and CXCL8 Facilitate Breast Tumor Growth By Promoting Angiogenesis

  2017cites this paper
• The role of interleukin 8 and matrix metalloproteinases 2 and 9 in breast cancer treated with tamoxifen

  2017cites this paper
• The Fli‐1 transcription factor is a critical regulator for controlling the expression of chemokine C‐X‐C motif ligand 2 (CXCL2)

  2017cites this paper
• A niche that triggers aggressiveness within BRCA1-IRIS overexpressing triple negative tumors is supported by reciprocal interactions with the microenvironment

  2017cites this paper
• Interleukin 8 in progression of hormone-dependent early breast cancer

  2017cites this paper
• The clinical and prognostic value of CXCL8 in cervical carcinoma patients: immunohistochemical analysis

  2017cites this paper
• Cancer Stem Cells and Metastasis.

  2017cites this paper
• Letrozole-induced functional changes in carcinoma-associated fibroblasts and their influence on breast cancer cell biology

  2016cites this paper
• Mucinous and serous ovarian carcinoma cells interact differently with stromal fibroblasts

  2016cites this paper
• The interconnected role of chemokines and estrogen in bone metabolism.

  2016cites this paper
• CXCL3 positively regulates adipogenic differentiation

  2016cites this paper
• Tumor-associated macrophage-derived CXCL8 could induce ERα suppression via HOXB13 in endometrial cancer.

  2016cites this paper
• The role of CXCR3 and its ligands in renal transplant outcome

  2016cites this paper
• Cytokine Regulation of Metastasis and Tumorigenicity.

  2016cites this paper
• SCOUP: a probabilistic model based on the Ornstein–Uhlenbeck process to analyze single-cell expression data during differentiation

  2016cites this paper
• Stemness-Related Transcriptional Factors and Homing Gene Expression Profiles in Hepatic Differentiation and Cancer

  2016cites this paper
• CXCL3 contributes to CD133+ CSCs maintenance and forms a positive feedback regulation loop with CD133 in HCC via Erk1/2 phosphorylation

  2016cites this paper
• Novel Biomarkers in the Management of HPV-Positive & -Negative Oropharyngeal Carcinoma

  2016cites this paper
• Overexpression of CXCL3 can enhance the oncogenic potential of prostate cancer

  2016cites this paper
• Neutrophils: important contributors to tumor progression and metastasis

  2015cites this paper